These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32188801)

  • 61. Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats.
    Hertzsch S; Roos A; Wess G
    J Vet Intern Med; 2019 May; 33(3):1242-1250. PubMed ID: 30990935
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Asymptomatic Hypertrophic Cardiomyopathy: Diagnosis and Therapy.
    Luis Fuentes V; Wilkie LJ
    Vet Clin North Am Small Anim Pract; 2017 Sep; 47(5):1041-1054. PubMed ID: 28662873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Aortic annular plane systolic excursion in cats with hypertrophic cardiomyopathy.
    Dutton LC; Spalla I; Seo J; Silva J; Novo Matos J
    J Vet Intern Med; 2024; 38(1):61-70. PubMed ID: 38038190
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Two-dimensional echocardiographic assessment of the feline left atrium.
    Abbott JA; MacLean HN
    J Vet Intern Med; 2006; 20(1):111-9. PubMed ID: 16496930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of spironolactone on diastolic function and left ventricular mass in Maine Coon cats with familial hypertrophic cardiomyopathy.
    MacDonald KA; Kittleson MD; Kass PH; White SD
    J Vet Intern Med; 2008; 22(2):335-41. PubMed ID: 18346145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Associations among echocardiography, cardiac biomarkers, insulin metabolism, morphology, and inflammation in cats with asymptomatic hypertrophic cardiomyopathy.
    van Hoek I; Hodgkiss-Geere H; Bode EF; Hamilton-Elliott J; Mõtsküla P; Palermo V; Pereira YM; Culshaw GJ; Ivanova A; Dukes-McEwan J
    J Vet Intern Med; 2020 Mar; 34(2):591-599. PubMed ID: 32045061
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In patients with hypertrophic cardiomyopathy myocardial fibrosis is associated with both left ventricular and left atrial dysfunction.
    Prinz C; Van Buuren F; Bogunovic N; Bitter T; Faber L; Horstkotte D
    Acta Cardiol; 2012 Apr; 67(2):187-93. PubMed ID: 22641976
    [TBL] [Abstract][Full Text] [Related]  

  • 68. International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.
    Fox PR; Keene BW; Lamb K; Schober KA; Chetboul V; Luis Fuentes V; Wess G; Payne JR; Hogan DF; Motsinger-Reif A; Häggström J; Trehiou-Sechi E; Fine-Ferreira DM; Nakamura RK; Lee PM; Singh MK; Ware WA; Abbott JA; Culshaw G; Riesen S; Borgarelli M; Lesser MB; Van Israël N; Côté E; Rush JE; Bulmer B; Santilli RA; Vollmar AC; Bossbaly MJ; Quick N; Bussadori C; Bright JM; Estrada AH; Ohad DG; Fernández-Del Palacio MJ; Lunney Brayley J; Schwartz DS; Bové CM; Gordon SG; Jung SW; Brambilla P; Moïse NS; Stauthammer CD; Stepien RL; Quintavalla C; Amberger C; Manczur F; Hung YW; Lobetti R; De Swarte M; Tamborini A; Mooney CT; Oyama MA; Komolov A; Fujii Y; Pariaut R; Uechi M; Tachika Ohara VY
    J Vet Intern Med; 2018 May; 32(3):930-943. PubMed ID: 29660848
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Echocardiography, electrocardiography, and radiography of cats with dilatation cardiomyopathy, hypertrophic cardiomyopathy, and hyperthyroidism.
    Moise NS; Dietze AE; Mezza LE; Strickland D; Erb HN; Edwards NJ
    Am J Vet Res; 1986 Jul; 47(7):1476-86. PubMed ID: 2943198
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Influence of left atrial function on Doppler transmitral and pulmonary venous flow patterns in dilated and hypertrophic cardiomyopathy: evaluation of left atrial appendage function by transesophageal echocardiography.
    Ito T; Suwa M; Hirota Y; Otake Y; Moriguchi A; Kawamura K
    Am Heart J; 1996 Jan; 131(1):122-30. PubMed ID: 8553998
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
    Masaki M; Mano T; Eguchi A; Fujiwara S; Sugahara M; Hirotani S; Tsujino T; Komamura K; Koshiba M; Masuyama T
    Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of radial and circumferential strain analysis using 2D speckle tracking echocardiography in cats.
    Takano H; Isogai T; Aoki T; Wakao Y; Fujii Y
    J Vet Med Sci; 2015 Feb; 77(2):193-201. PubMed ID: 25373881
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anterior mitral valve leaflet length in cats with hypertrophic cardiomyopathy.
    Seo J; Matos JN; Payne JR; Fuentes VL; Connolly DJ
    J Vet Cardiol; 2021 Oct; 37():62-70. PubMed ID: 34610570
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study.
    Balaji S; DiLorenzo MP; Fish FA; Etheridge SP; Aziz PF; Russell MW; Tisma S; Pflaumer A; Sreeram N; Kubus P; Law IH; Kantoch MJ; Kertesz NJ; Strieper M; Erickson CC; Moore JP; Nakano SJ; Singh HR; Chang P; Cohen M; Fournier A; Ilina MV; Smith RT; Zimmerman F; Horndasch M; Li W; Batra A; Liberman L; Hamilton R; Janson CM; Sanatani S; Zeltser I; McDaniel G; Blaufox AD; Garnreiter JM; Katcoff H; Shah M
    Heart Rhythm; 2019 Oct; 16(10):1462-1467. PubMed ID: 31026510
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats.
    Bright JM; Golden AL
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):1023-34. PubMed ID: 1683045
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Echocardiographic assessment of left ventricular geometry and the mitral valve apparatus in cats with hypertrophic cardiomyopathy.
    Schober K; Todd A
    J Vet Cardiol; 2010 Apr; 12(1):1-16. PubMed ID: 20185379
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
    Tapp RJ; Sharp A; Stanton AV; O'Brien E; Chaturvedi N; Poulter NR; Sever PS; Thom SA; Hughes AD; Mayet J;
    J Am Coll Cardiol; 2010 Apr; 55(17):1875-81. PubMed ID: 20413040
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Myocardial torsional deformations in cats with hypertrophic cardiomyopathy using two-dimensional speckle-tracking echocardiography.
    Suzuki R; Mochizuki Y; Yoshimatsu H; Ohkusa T; Teshima T; Matsumoto H; Koyama H
    J Vet Cardiol; 2016 Dec; 18(4):350-357. PubMed ID: 27515828
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myocardial transcription of inflammatory and remodeling markers in cats with hypertrophic cardiomyopathy and systemic diseases associated with an inflammatory phenotype.
    Fonfara S; Kitz S; Monteith G; Hahn S; Kipar A
    Res Vet Sci; 2021 May; 136():484-494. PubMed ID: 33848803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial.
    Kaplan JL; Rivas VN; Walker AL; Grubb L; Farrell A; Fitzgerald S; Kennedy S; Jauregui CE; Crofton AE; McLaughlin C; Van Zile R; DeFrancesco TC; Meurs KM; Stern JA
    J Am Vet Med Assoc; 2023 Nov; 261(11):1628-1637. PubMed ID: 37495229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.